Clinical Trial Update: A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN) [Phase 2]

View source ↗

Summary

Phase II randomized, double-blind, placebo-controlled trial evaluating prednisone therapy for HIV-associated nephropathy (HIVAN).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-associated Nephropathy
• HIV Infections

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, AIDS-Associated Nephropathy | Phase 2 | Status: COMPLETED